OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
Antonio Inserra, Alexandre Piot, Danilo De Gregorio, et al.
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 733-754
Closed Access | Times Cited: 7
Antonio Inserra, Alexandre Piot, Danilo De Gregorio, et al.
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 733-754
Closed Access | Times Cited: 7
Showing 7 citing articles:
TAAR1 as an emerging target for the treatment of psychiatric disorders
Jianfeng Liu, Ruyan Wu, Jun‐Xu Li
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108580-108580
Closed Access | Times Cited: 11
Jianfeng Liu, Ruyan Wu, Jun‐Xu Li
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108580-108580
Closed Access | Times Cited: 11
Serotonergic neuromodulation of synaptic plasticity
Guilherme Shigueto Vilar Higa, Felipe José Costa Viana, José Fernando de Oliveira, et al.
Neuropharmacology (2024) Vol. 257, pp. 110036-110036
Closed Access | Times Cited: 3
Guilherme Shigueto Vilar Higa, Felipe José Costa Viana, José Fernando de Oliveira, et al.
Neuropharmacology (2024) Vol. 257, pp. 110036-110036
Closed Access | Times Cited: 3
Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
Hong-Qing Zhao, Yang Liu, Na Cai, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2143-2167
Open Access | Times Cited: 2
Hong-Qing Zhao, Yang Liu, Na Cai, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2143-2167
Open Access | Times Cited: 2
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
Giuseppe Pasculli, Pierpaolo Busan, Eric S. Jackson, et al.
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Giuseppe Pasculli, Pierpaolo Busan, Eric S. Jackson, et al.
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
The selective 5-HT2Areceptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents
Anders A. Jensen, Cláudia R. Cecchi, Meghan Hibicke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Anders A. Jensen, Cláudia R. Cecchi, Meghan Hibicke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis
Mattia Marchi, Riccardo Farina, Karim Rachedi, et al.
Journal of Psychopharmacology (2024)
Closed Access
Mattia Marchi, Riccardo Farina, Karim Rachedi, et al.
Journal of Psychopharmacology (2024)
Closed Access
Psychedelic use and bipolar disorder – An investigation of recreational use and its impact on mental health
Thomas D. Meyer, M.A. Ibrahim, L. Vale, et al.
Journal of Affective Disorders (2024)
Closed Access
Thomas D. Meyer, M.A. Ibrahim, L. Vale, et al.
Journal of Affective Disorders (2024)
Closed Access
